Health Canada has approved a new orthodontic tooth treatment called AcceleDent.

Highlights of AcceleDent

• AcceleDent is the first FDA-cleared “clinical approach to safely accelerate orthodontic tooth movement by applying gentle micropulses as a complement to existing orthodontic treatment”, says the Houston-based manufacturer of the treatment, OrthoAccel® Technologies.
• The device is a removable and non-invasive appliance (similar to a mouth guard) that a patient with braces wears in the mouth for 20 minutes per day to accelerate orthodontic tooth movement.
• According to media reports, in a randomized clinical trial paid for by the company, “the device demonstrated with statistical significance that it could accelerate teeth movement by 106% during the initial alignment phase and 38% to 50% during closure of extraction space. There was no evidence of damage of teeth roots or other adverse events caused by the appliance in the study.”
• The treatment received clearance in 2011 from the U.S. Food and Drug Administration as a Class II medical device. It’s also currently marketed in the United Kingdom, across the European Union, Australia and South Korea.
• The cost of treatment is unclear. In the U.S., the cost appears to be rolled into the overall cost of orthodontics.
• Learn more about how AcceleDent works.

ENCOMPASS Benefits will be monitoring these costs over the coming months and will be communicating more as we hear more details.

Article Source:  SmallBizAdvisor.

Learn more about Orthodontic Coverage for your Group Health Insurance

ENCOMPASS Benefits can help. Please contact ENCOMPASS to learn more.